Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Underwood

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMC Cancer|September 1, 2022
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trialElizabeth Smyth, Kelly Cozens, Daniel Griffiths, et al.
The British Journal of Surgery|August 24, 2022
Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/Perioperative Quality Initiative (POQI) consensus statement on intraoperative and postoperative interventions to reduce pulmonary complications after oesophagectomyPritam Singh, James Gossage, Sheraz Markar, et al.
BJR Open|June 9, 2025
Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods studyKieran G Foley, Cherish Boxall, James Franklin, et al.
Eclinicalmedicine|October 13, 2025
Oesophageal cancer multi-disciplinary tool: a co-designed, externally validated, machine learning tool for oesophageal cancer decision makingNavamayooran Thavanesan, Mohammad Naiseh, Miguel Terol, et al.
Lab on a Chip|July 9, 2021
Dual dean entrainment with volume ratio modulation for efficient droplet co-encapsulation: extreme single-cell indexingJack Harrington, Luis Blay Esteban, Jonathan Butement, et al.
The British Journal of Surgery|February 21, 2025
LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort studyHeidi Paine, Swathikan Chidambaram, Asif Johar, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Nature Genetics|September 6, 2016
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
International Journal of Surgery (London, England)|July 16, 2022
The first international Delphi consensus statement on Laparoscopic Gastrointestinal surgeryIslam Omar, Karl Miller, Brijesh Madhok, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Cancer|September 1, 2022
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trialElizabeth Smyth, Kelly Cozens, Daniel Griffiths, et al.
The British Journal of Surgery|August 24, 2022
Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/Perioperative Quality Initiative (POQI) consensus statement on intraoperative and postoperative interventions to reduce pulmonary complications after oesophagectomyPritam Singh, James Gossage, Sheraz Markar, et al.
BJR Open|June 9, 2025
Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods studyKieran G Foley, Cherish Boxall, James Franklin, et al.
Eclinicalmedicine|October 13, 2025
Oesophageal cancer multi-disciplinary tool: a co-designed, externally validated, machine learning tool for oesophageal cancer decision makingNavamayooran Thavanesan, Mohammad Naiseh, Miguel Terol, et al.
Lab on a Chip|July 9, 2021
Dual dean entrainment with volume ratio modulation for efficient droplet co-encapsulation: extreme single-cell indexingJack Harrington, Luis Blay Esteban, Jonathan Butement, et al.
The British Journal of Surgery|February 21, 2025
LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort studyHeidi Paine, Swathikan Chidambaram, Asif Johar, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Nature Genetics|September 6, 2016
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
The Lancet. Gastroenterology & Hepatology|September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
International Journal of Surgery (London, England)|July 16, 2022
The first international Delphi consensus statement on Laparoscopic Gastrointestinal surgeryIslam Omar, Karl Miller, Brijesh Madhok, et al.
Pageof 3